X. Ju

发表

Phosphorothioate‑modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy.

Di Chen, Yuxin Shen, Huojun Zhang, 2017, Molecular medicine reports.

Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

Zhiyong Yuan, Xianzhi Zhao, Huojun Zhang, 2018, Radiation Oncology.

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China

Yusheng Ye, Xu Gao, Xianzhi Zhao, 2022, Frontiers in Oncology.

A modified formula for dose calculations of stereotactic ablative body radiotherapy for non-small cell lung cancer.

Huojun Zhang, Z. Dai, Xiaofei Zhu, 2017, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy

Yusheng Ye, T. Su, Xianzhi Zhao, 2020, Frontiers in Oncology.

Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study

Yusheng Ye, T. Su, Xianzhi Zhao, 2020, Therapeutic advances in medical oncology.

Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles

Yusheng Ye, Xianzhi Zhao, Yuxin Shen, 2020, Cancer science.

Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2019, International journal of radiation oncology, biology, physics.

Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score).

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer management and research.

Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.

Yusheng Ye, G. Jin, Xianzhi Zhao, 2022, The Lancet. Oncology.

Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial.

Yusheng Ye, G. Jin, Xianzhi Zhao, 2021, The Lancet. Oncology.

Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer medicine.

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis

Zhen Jia, Yuxin Shen, Huojun Zhang, 2019, Front. Oncol..

Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2016, BMJ Open.

Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database

Yuxin Shen, Huojun Zhang, D. Shi, 2018, Cancer management and research.

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer

Yuxin Shen, Huojun Zhang, Xiaofei Zhu, 2017, Cancer medicine.

Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications

Di Chen, Xianzhi Zhao, Yuxin Shen, 2020, Cancer biology & medicine.

Clinical efficacy of Stereotactic Body Radiation Therapy (SBRT) for adrenal gland metastases: A multi-center retrospective study from China

Ping Wang, Yongchun Song, H. Zhuang, 2020, Scientific Reports.

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases

Yuxin Shen, Huojun Zhang, Hongliang Xie, 2021, Frontiers in Oncology.

Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study

Huojun Zhang, X. Ju, S. Qing, 2017, Radiation oncology.

Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shells

Huojun Zhang, Z. Dai, Xiaofei Zhu, 2018, Radiation Oncology.

Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

Xianzhi Zhao, Huojun Zhang, Xiaofei Zhu, 2018, Radiation oncology.

Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China

Yusheng Ye, Xianzhi Zhao, Huojun Zhang, 2021, Journal of Cancer Research and Clinical Oncology.